These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19761421)

  • 1. Clinical and biological diversity of splenic marginal zone lymphoma.
    Matutes E
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1185-9. PubMed ID: 19761421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Splenic marginal zone lymphoma].
    Dimopoulos K; Pedersen M
    Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: current knowledge and future directions.
    Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
    Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
    Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
    Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone lymphoma in a patient with chronic hepatitis B.
    Christou L; Kalambokis G; Bai M; Kamina S; Tsianos EV
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):511-2. PubMed ID: 20076834
    [No Abstract]   [Full Text] [Related]  

  • 9. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Splenic pathology. Case no 2. Splenic marginal zone B-cell lymphoma].
    Traverse-Glehen A; Berger F
    Ann Pathol; 2010 Jun; 30(3):206-10. PubMed ID: 20621598
    [No Abstract]   [Full Text] [Related]  

  • 11. Marginal zone lymphomas, MALT and splenic types.
    De Wolf-Peeters C
    Adv Clin Path; 2000 Oct; 4(4):190-2. PubMed ID: 11436156
    [No Abstract]   [Full Text] [Related]  

  • 12. Splenic marginal zone lymphoma in 5 dogs (2001-2008).
    Stefanello D; Valenti P; Zini E; Comazzi S; Gelain ME; Roccabianca P; Avallone G; Caniatti M; Marconato L
    J Vet Intern Med; 2011; 25(1):90-3. PubMed ID: 21092007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-MALT marginal zone lymphomas.
    Thieblemont C
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv70-3. PubMed ID: 18519410
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
    Matutes E; Oscier D; Montalban C; Berger F; Callet-Bauchu E; Dogan A; Felman P; Franco V; Iannitto E; Mollejo M; Papadaki T; Remstein ED; Salar A; Solé F; Stamatopoulos K; Thieblemont C; Traverse-Glehen A; Wotherspoon A; Coiffier B; Piris MA
    Leukemia; 2008 Mar; 22(3):487-95. PubMed ID: 18094718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and management of marginal zone lymphomas.
    Thieblemont C
    Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma.
    Vlădăreanu AM; Onisâi M; Ciufu C; Bumbea H; Cîşleanu D; Voican I; Nicolescu A; Radeşi S; Vintilescu A; Băluţă C; Dobrea C; Savlovschi C; Grecu L; Serban D; Serafim G
    Rom J Intern Med; 2009; 47(2):191-9. PubMed ID: 20067170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-faggot cells in splenic marginal zone lymphoma.
    Wilson J
    Br J Haematol; 2023 Apr; 201(1):7. PubMed ID: 36606572
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of marginal zone lymphoma.
    Reid R; Friedberg JW
    Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenic lymphomas: is there still a role for splenectomy?
    Martin P; Rutherford S; Leonard JP
    Oncology (Williston Park); 2012 Feb; 26(2):204, 206. PubMed ID: 22489357
    [No Abstract]   [Full Text] [Related]  

  • 20. Marginal zone lymphomas.
    Zucca E; Bertoni F; Stathis A; Cavalli F
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):883-901, viii. PubMed ID: 18954742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.